These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24959119)

  • 1. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.
    Vallelunga A; Ragusa M; Di Mauro S; Iannitti T; Pilleri M; Biundo R; Weis L; Di Pietro C; De Iuliis A; Nicoletti A; Zappia M; Purrello M; Antonini A
    Front Cell Neurosci; 2014; 8():156. PubMed ID: 24959119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease.
    Vallelunga A; Iannitti T; Capece S; Somma G; Russillo MC; Foubert-Samier A; Laurens B; Sibon I; Meissner WG; Barone P; Pellecchia MT
    Front Aging Neurosci; 2021; 13():632891. PubMed ID: 34381349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
    Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
    Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy.
    Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG
    J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients.
    Jiang Y; Chen J; Sun Y; Li F; Wei L; Sun W; Deng J; Yuan Y; Wang Z
    Front Neurol; 2021; 12():738530. PubMed ID: 34899562
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
    Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
    Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
    Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations.
    Zadehbagheri F; Hosseini E; Bagheri-Hosseinabadi Z; Rekabdarkolaee HM; Sadeghi I
    J Psychiatr Res; 2019 Feb; 109():185-192. PubMed ID: 30557705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
    Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
    J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics.
    Ramaswamy P; Christopher R; Pal PK; Yadav R
    J Neurol Sci; 2018 Nov; 394():26-37. PubMed ID: 30196132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA expression profiling in patients with multiple system atrophy.
    Kume K; Iwama H; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Fujikawa K; Hirose K; Masugata H; Touge T; Masaki T
    Mol Med Rep; 2018 Jan; 17(1):852-860. PubMed ID: 29115515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.